Machine Learning

Tiger Data's new self-managed database brings modern, open-source power to critical industries, challenging the reign of legacy data historian platforms.

While competitors test AI, EASE Logistics has deployed its AMMI platform, processing 40,000 tasks weekly and slashing quote times from minutes to seconds.

DecisionHR hires PEO veteran Josh McIntosh as CRO, signaling a strategic push for market share in the booming, competitive HR outsourcing industry.

As pay transparency and economic pressures mount, a new unified platform aims to democratize compensation intelligence across the entire organization.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

Atsena Therapeutics gets the green light for the final trial phase of a promising gene therapy, offering the first real hope for patients with X-linked retinoschisis.

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

The B2B media giant expands its data-driven model to the UK's lucrative financial services sector, leveraging AI-era content strategies for growth.

A new comparison reveals stark differences in SDK generators, showing the shift from developer tools to critical infrastructure for security, compliance, and AI.

With developer devices now the main front in supply chain wars, Aikido Security launches a new tool to block threats before they ever get installed.

At Auto China 2026, JETOUR unveils its 'Travel+' strategy, a dual-brand gambit, and a celebrity partnership aimed at redefining automotive ownership.

Solera's new AI Engine is more than a feature; it's a foundational shift aiming to connect the entire automotive value chain. Here's what it means.

Verdent's new platform acts as an AI engineering team, letting non-coders build apps and challenging the future of software development itself.

A new US-India alliance combines DataOS tech with financial expertise, promising to help banks accelerate AI adoption by leaving legacy data in place.

PeptiDream and Asahi Kasei's novel drug candidate, AK1940, begins Phase 1 trials, aiming for a safer, more targeted approach to treating autoimmune diseases.

As AI pushes data centers to their limits, STL launches Neuralis, a new connectivity solution designed to be the nervous system for America's AI future.

With multiple top honors at the 2026 EdTech Digest Awards, Cambium Learning Group cements its role as a leader in literacy and teacher development.

Upcoming Phase 1 data for ABCL635 could validate a novel antibody approach for hot flashes, challenging the market and offering new hope for millions.

Publicly traded CNTN releases its Q1 2026 report on the Canton Network, revealing institutional adoption metrics and a unique token model for finance.

A breakthrough drug for pediatric Hunter syndrome, AVLAYAH™, is now accessible via home infusion through an exclusive Orsini and Denali partnership.